“Transformations in care of aortic stenosis over the last two decades have led to an evolution in our understanding of the epidemiology and natural history of AS. Multiple contemporary population studies have suggested that moderate AS carries a similarly poor prognosis to severe AS, suggesting that therapies and the process of care for moderate AS need to be improved. The AHA is leading the way in improving awareness of moderate AS and facilitating research to improve its care and prognosis.”

Sreekanth Vemulapalli, MD

Duke University Health System

Associate Professor of Medicine/Cardiology; Medical Director, Duke Echo Lab and Cardiac Diagnostic Unit; Member, Duke Clinical Research Institute; Member, Duke-Margolis Center for Health Policy

“Moderate aortic stenosis is not a benign diagnosis—it is an active phase of myocardial stress. It is the moment to engage the heart valve team, because treating it thoughtfully and early is an investment in preserving ventricular function, preventing irreversible remodeling, and changing the trajectory of the disease rather than reacting to its consequences.”

Jeanne Huchting, ACNP

University of California Los Angeles Cardiovascular Center

TAVR Coordinator

“Patients with moderate aortic stenosis often fall into a gray zone of care. From a care coordination perspective, innovation in earlier identification and novel approaches that may slow progression offer an opportunity to bring structure, consistency, and patient engagement to this population. By closing gaps in follow-up and navigation, we can improve continuity of care and positively impact patient outcomes.”

Misty Theriot, BSN, RN, CPHQ, FACC

Lake Charles Memorial Hospital

Valve Clinic Coordinator